| Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma (NCT04310943) | Zhou Chengzhi | 2021-03-01 |
| Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults (NCT04845178) | AEON Biopharma, Inc. | 2021-03-01 |
| A Clinical Trial of Esophagectomy for Esophageal Carcinoma (NCT06691503) | Sun Yat-sen University | 2021-03-01 |
| Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder. (NCT03885141) | Biolab Sanus Farmaceutica | 2021-03-01 |
| Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer (NCT04345913) | National Cancer Institute (NCI) | 2021-03-01 |
| Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer (NCT07320586) | Shandong Tumor Hospital | 2021-03-01 |
| Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START) (NCT05035745) | National University Hospital, Singapore | 2021-03-01 |
| Effect of Abaloparatide on Lumbar Disc Degeneration (NCT03708926) | Johns Hopkins University | 2021-03-01 |
| Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma (NCT04714697) | Asan Medical Center | 2021-03-01 |
| Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer (NCT04828395) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-01 |
| Second-line Surufatinib Combined With Chemotherapy in Advanced CRC (NCT04734249) | Fujian Cancer Hospital | 2021-03-01 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) (NCT04927169) | Revimmune | 2021-03-01 |
| Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients (NCT04287829) | The Netherlands Cancer Institute | 2021-03-01 |
| A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC) (NCT04767295) | Hunan Cancer Hospital | 2021-03-01 |
| Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries (NCT04813016) | National Cancer Institute, Egypt | 2021-03-01 |
| The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients (NCT03003195) | University of Arkansas | 2021-03-01 |
| Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer (NCT04739670) | Peter MacCallum Cancer Centre, Australia | 2021-03-01 |
| Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection (NCT04505501) | Thai Red Cross AIDS Research Centre | 2021-03-01 |
| SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs (NCT04764214) | Fudan University | 2021-03-01 |
| Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery (NCT04452461) | Hamilton Health Sciences Corporation | 2021-03-01 |
| Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110) (NCT04609280) | University of Maryland, Baltimore | 2021-03-01 |
| SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer (NCT04797507) | Peking Union Medical College Hospital | 2021-03-01 |
| Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors (NCT04765462) | Chinese PLA General Hospital | 2021-03-01 |
| Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC (NCT05400070) | Tang-Du Hospital | 2021-03-01 |
| The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis (NCT05356793) | Sacsh | 2021-03-01 |
| A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor (NCT04691388) | Zhejiang Cancer Hospital | 2021-03-01 |
| A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma (NCT04981899) | St. Petersburg State Pavlov Medical University | 2021-03-01 |
| Efficacy of Diuretics in Kidney Disease (NCT04542304) | Stanford University | 2021-03-01 |
| 5-HTP and Creatine for Depression (NCT04395183) | University of Utah | 2021-03-01 |
| The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC (NCT04830267) | Chongqing University Cancer Hospital | 2021-03-01 |
| A Pilot Study of the Effects of BCG Immunization on CSF and Blood-based Biomarkers in Older Adults. (NCT04507126) | Massachusetts General Hospital | 2021-03-01 |
| Denture Adhesives for Elderly Denture Wearers (NCT04927767) | The University of Hong Kong | 2021-03-01 |
| Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML (NCT04254640) | Sun Yat-sen University | 2021-03-01 |
| Clinical Trial of Ruxian Zengsheng No. 1 Decoction (NCT04767620) | Jiuda Zhao | 2021-03-01 |
| Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin (NCT05500937) | First Affiliated Hospital Xi'an Jiaotong University | 2021-03-01 |
| Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration (NCT04700423) | Jennifer Keiser | 2021-03-01 |
| Talazoparib Maintenance Therapy in Triple-negative Breast Cancer (NCT04755868) | Yonsei University | 2021-03-01 |
| The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma (NCT04769076) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-03-01 |
| Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress (NCT04728698) | Sorrento Therapeutics, Inc. | 2021-03-01 |
| PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC (NCT04809779) | First Affiliated Hospital, Sun Yat-Sen University | 2021-03-01 |
| Evaluation of Low-Level Laser Therapy Efficacy in Pain Management of Grade 2 Oral Mucositis Induced by Radiotherapy or Chemoradiotherapy: a Study in Patients With Upper Aerodigestive Tract Cancer (NCT03955224) | Institut Claudius Regaud | 2021-03-01 |
| A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 (NCT04524208) | Karsten Gavenis | 2021-03-01 |
| Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC) (NCT04727853) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-03-01 |
| Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer (NCT04808687) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-01 |
| Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome (NCT04776876) | M.D. Anderson Cancer Center | 2021-03-01 |
| Magnesium Sulfate for Analgesia in Pediatric Transplant (NCT04812028) | University of Minnesota | 2021-03-01 |
| Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer (NCT04777162) | Peking University | 2021-03-01 |
| Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI (NCT04232657) | VA Office of Research and Development | 2021-03-01 |
| A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis (NCT04711148) | Beijing InnoCare Pharma Tech Co., Ltd. | 2021-03-01 |
| Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. (NCT04553159) | Makerere University | 2021-03-01 |
| Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma (NCT04566887) | University Health Network, Toronto | 2021-03-01 |
| Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy (NCT04200989) | Scripps Health | 2021-03-01 |
| Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery (NCT04636567) | Li-Cor, Inc. | 2021-03-01 |
| Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma (NCT04331093) | Di Wu | 2021-03-01 |
| Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions (NCT04790747) | Zhejiang University | 2021-03-01 |
| First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC (NCT06238752) | Renmin Hospital of Wuhan University | 2021-03-01 |
| The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. (NCT04433845) | Sheppard Pratt Health System | 2021-03-01 |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer (NCT03281681) | DelMar Pharmaceuticals, Inc. | 2021-03-01 |
| Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout (NCT04772352) | Ningbo No. 1 Hospital | 2021-03-01 |
| Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP. (NCT04796324) | Allarity Therapeutics | 2021-03-01 |
| The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia (NCT04747080) | Peking University People's Hospital | 2021-03-01 |
| Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty (NCT04295486) | University of Miami | 2021-03-01 |
| Myofascial Pain Patients' Response to the Administration of Low Doses of Amitriptyline and Citalopram Compared With the Use of Bite Splint (NCT04777838) | University of Coimbra | 2021-03-01 |
| Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis (NCT05033639) | Ilocos Training and Regional Medical Center | 2021-03-01 |
| CAR-T Cells for HIV Infection (NCT04648046) | Steven Deeks | 2021-03-01 |
| The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis (NCT04789837) | Sadat City University | 2021-03-01 |
| A Phase 2 Study of Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy (NCT04824924) | Shanghai Jiao Tong University School of Medicine | 2021-03-01 |
| Effect of mgso4 on Oxygenation and Lung Mechanics in Morbidly Obese Patients During Bariatric Surgery (NCT04769440) | Ain Shams University | 2021-03-01 |
| An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) (NCT04433858) | Sheppard Pratt Health System | 2021-03-01 |
| Safety and Efficacy of Baricitinib for COVID-19 (NCT04340232) | University of Colorado, Denver | 2021-03-01 |
| MentorApp for Cancer Patient's Remote Monitoring (NCT04710472) | Associacao de Investigacao de Cuidados de Suporte em Oncologia | 2021-03-01 |
| Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) (NCT04746911) | Arcutis Biotherapeutics, Inc. | 2021-03-01 |
| Efficacy of Botulinum Toxin in Temporomandibular Disorders (NCT05651256) | University of Salamanca | 2021-03-01 |
| Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy (NCT04770272) | Palleos Healthcare GmbH | 2021-03-01 |
| TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma (NCT04923529) | The University of Hong Kong | 2021-03-01 |
| Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer (NCT04624711) | The First Affiliated Hospital with Nanjing Medical University | 2021-03-01 |
| Efficacy and Safety of Sintilimab Combined With Regorafenib and Cetuximab / Sintilimab Combined With Regorafenib in Posterior Line Therapy of Advanced Colorectal Cancer (Regosinti) (NCT04745130) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-01 |
| Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy (NCT04155099) | Ochsner Health System | 2021-03-01 |
| Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19 (NCT04678830) | CytoDyn, Inc. | 2021-03-01 |
| Saccharomyces Cerevisiae for Irritable Bowel Syndrome (NCT05149599) | Ziauddin University | 2021-03-01 |
| Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166) (NCT04670120) | Beijing Chest Hospital | 2021-03-01 |
| Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse (NCT04758000) | Istituto Ortopedico Rizzoli | 2021-03-01 |
| ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases (NCT03448666) | European Institute of Oncology | 2021-03-01 |
| Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse (NCT04784221) | Centre Francois Baclesse | 2021-03-01 |
| Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction (NCT03533153) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-03-01 |
| Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy (NCT04579133) | Latin American Cooperative Oncology Group | 2021-03-01 |
| Neoadjuvant Radiation in Locally Advanced Breast Cancer (NCT05479409) | Fudan University | 2021-03-01 |
| Romosozumab in Women With Chronic SCI (NCT04708886) | Northwestern University | 2021-03-01 |
| Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage (NCT04714177) | First Affiliated Hospital, Sun Yat-Sen University | 2021-03-01 |
| Do Flavors Increase the Addiction Potential of Nicotine? (NCT04696380) | University of Vermont | 2021-03-01 |
| A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring (NCT04290182) | Karolinska University Hospital | 2021-03-01 |
| Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer. (NCT05997524) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2021-03-01 |
| Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer (NCT04733963) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-03-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis (NCT04607655) | Galecto Biotech AB | 2021-03-01 |
| COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2 (NCT04858451) | Thirty Respiratory Limited | 2021-03-01 |
| Pilot Trial of XFBD, a TCM, in Persons With COVID-19 (NCT04810689) | Darcy Spicer | 2021-03-01 |
| Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury (NCT04586712) | University of Florida | 2021-03-01 |
| PREemptive Analgesia With preGABAlin in HEART Surgery (NCT04173390) | InCor Heart Institute | 2021-03-01 |
| Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer (NCT04781413) | Ruijin Hospital | 2021-03-01 |
| Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC (NCT04905550) | Chongqing University Cancer Hospital | 2021-03-01 |